Duloxetine HCL DR 20 MG cap 1000S
Ended Awarded
- Contract number
- SPE2DB25FQ85X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,235
Award facts
- Contract value 100% obligated
- $1,235.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of 1,000 units of Duloxetine HCL DR 20 mg capsules at a ceiling value of $1,235.18. This contract was awarded without a set-aside designation through open competition and is scheduled for completion by September 24, 2025. The delivery location is the company's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor contract running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves critical federal medical procurement needs, particularly for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency covering a wide spectrum of pharmaceutical products, including neurological treatments, pain management medications, and specialized medical supplies. All reviewed contract awards demonstrate the company's capability to meet federal procurement requirements through competitive acquisition, with delivery orders consistently employing firm fixed pricing. The DLA is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple awards across separate regions, positioning AmerisourceBergen to continue serving customers including the Defense Health Agency and U.S. Coast Guard through this flexible and comprehensive contract vehicle.
Quick answers
Who was awarded contract SPE2DB25FQ85X?
SPE2DB25FQ85X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FQ85X worth?
The government has obligated $1,235 on SPE2DB25FQ85X.
Is contract SPE2DB25FQ85X an order under another contract?
Yes. SPE2DB25FQ85X is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ85X competed?
The extent of competition for SPE2DB25FQ85X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award